Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
tramadol hydrochloride, Quantity: 100 mg
Sandoz Pty Ltd
Tablet, modified release
Excipient Ingredients: hypromellose; lactose monohydrate; calcium hydrogen phosphate dihydrate; magnesium stearate; sodium starch glycollate; hydrogenated castor oil; povidone; microcrystalline cellulose; maize starch; colloidal anhydrous silica; Colour
Oral
20 tablets
(S4) Prescription Only Medicine
Tramadol Sandoz SR is indicated for the management of severe pain where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? requires daily, continuous, long term treatment. Tramadol Sandoz SR is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. Tramadol Sandoz SR is not indicated as an as-needed (PRN) analgesia.
Visual Identification: Flat round bi-layer tablet with facet, initial layer white, slow release layer green with one-sided identification mark "T R/ 100 R"; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2005-03-24
TRAMADOL SANDOZ SR ® 1 TRAMADOL SANDOZ SR ® _tramadol hydrochloride sustained-release tablets _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Tramadol Sandoz SR. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT TRAMADOL SANDOZ SR IS USED FOR The name of your medicine is Tramadol Sandoz SR. This medicine is used to relieve severe pain which requires daily, long term treatment. It contains the active ingredient tramadol hydrochloride. Tramadol hydrochloride belongs to a group of medicines called opioid analgesics (pain relievers). Tramadol Sandoz SR tablets are designed to release active medicine gradually over several hours. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. Tramadol Sandoz SR is available only on a doctor’s prescription. TRAMADOL SANDOZ SR TABLETS IS FOR USE IN ADULTS AND CHILDREN OVER 12 YEARS OF AGE. It should not be used in children under the age of 12 years or following the removal of tonsils and/or adenoids in people under 18. BEFORE YOU TAKE TRAMADOL SANDOZ SR _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE THIS MEDICINE IF YOU HAVE AN ALLERGY TO: • tramadol hydrochloride, the active ingredient or to any of the other ingredients listed at the end of this leaflet under Product Description. • any other similar medicines known as opioid analgesics e.g. morphine, codeine. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing WARNING LIMITATIONS OF USE Tramadol Sandoz SR should only be used when your d Lugege kogu dokumenti
220208-Tramadol Sandoz SR-pi Page 1 of 19 AUSTRALIAN PRODUCT INFORMATION TRAMADOL SANDOZ ® SR (TRAMADOL HYDROCHLORIDE) SUSTAINED RELEASE TABLETS 1. NAME OF THE MEDICINE Tramadol hydrochloride 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each Tramadol Sandoz ® SR 100 mg sustained release tablet contains 100 mg Tramadol hydrochloride. Each Tramadol Sandoz ® SR 150 mg sustained release tablet contains 150 mg Tramadol hydrochloride. Each Tramadol Sandoz ® SR 200 mg sustained release tablet contains 200 mg Tramadol hydrochloride. Excipients with known effects: Sugars as lactose WARNINGS LIMITATIONS OF USE Because of the risks associated with the use of opioids, Tramadol Sandoz SR should only be used in patients whom other treatment options, including non-opioid analgesics, are ineffective, not tolerated or otherwise inadequate to provide appropriate management of pain (see Section 4.4 Special warnings and precautions for use). HAZARDOUS AND HARMFUL USE Tramadol Sandoz SR poses risks of hazardous and harmful use which can lead to overdose and death. Assess the patient’s risk of hazardous and harmful use before prescribing and monitor the patient regularly during treatment (see Section 4.4 Special warnings and precautions for use). LIFE THREATENING RESPIRATORY DEPRESSION Serious, life-threatening or fatal respiratory depression may occur with the use of Tramadol Sandoz SR. Be aware of situations which increase the risk of respiratory depression, modify dosing in patients at risk and monitor patients closely, especially on initiation or following a dose increase (see Section 4.4 Special warnings and precautions for use). CONCOMITANT USE OF BENZODIAZEPINES AND OTHER CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS, INCLUDING ALCOHOL Concomitant use of opioids with benzodiazepines, gabapentinoids, antihistamines, tricyclic antidepressants, antipsychotics, cannabis or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma and death. Limit dosages and dur Lugege kogu dokumenti